17-51154266-G-A

Variant summary

Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_198175.1(NME1):​c.-108G>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.496 in 980,686 control chromosomes in the GnomAD database, including 123,333 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.54 ( 22561 hom., cov: 30)
Exomes 𝑓: 0.49 ( 100772 hom. )

Consequence

NME1
NM_198175.1 5_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -2.16
Variant links:
Genes affected
NME1-NME2 (HGNC:33531): (NME1-NME2 readthrough) This locus represents naturally occurring read-through transcription between the neighboring NME1 and NME2 genes. The significance of this read-through transcription and the function of the resulting protein product have not yet been determined. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Nov 2010]
NME1 (HGNC:7849): (NME/NM23 nucleoside diphosphate kinase 1) This gene (NME1) was identified because of its reduced mRNA transcript levels in highly metastatic cells. Nucleoside diphosphate kinase (NDK) exists as a hexamer composed of 'A' (encoded by this gene) and 'B' (encoded by NME2) isoforms. Mutations in this gene have been identified in aggressive neuroblastomas. Two transcript variants encoding different isoforms have been found for this gene. Co-transcription of this gene and the neighboring downstream gene (NME2) generates naturally-occurring transcripts (NME1-NME2), which encodes a fusion protein comprised of sequence sharing identity with each individual gene product. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 17-51154266-G-A is Benign according to our data. Variant chr17-51154266-G-A is described in ClinVar as [Benign]. Clinvar id is 2688150.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.663 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
NME1NM_000269.3 linkuse as main transcriptc.-5+604G>A intron_variant ENST00000393196.8 NP_000260.1 P15531-1A0A384MTW7
NME1NM_198175.1 linkuse as main transcriptc.-108G>A 5_prime_UTR_variant 2/6 NP_937818.1 P15531-2
NME1-NME2NM_001018136.3 linkuse as main transcriptc.-5+604G>A intron_variant NP_001018146.1 P22392-2
NME1-NME2NR_037149.2 linkuse as main transcriptn.146G>A non_coding_transcript_exon_variant 2/9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
NME1-NME2ENST00000555572 linkuse as main transcriptc.-108G>A 5_prime_UTR_variant 2/92 ENSP00000451932.1 Q32Q12
NME1ENST00000393196.8 linkuse as main transcriptc.-5+604G>A intron_variant 1 NM_000269.3 ENSP00000376892.3 P15531-1

Frequencies

GnomAD3 genomes
AF:
0.539
AC:
81547
AN:
151300
Hom.:
22531
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.670
Gnomad AMI
AF:
0.512
Gnomad AMR
AF:
0.507
Gnomad ASJ
AF:
0.473
Gnomad EAS
AF:
0.391
Gnomad SAS
AF:
0.354
Gnomad FIN
AF:
0.485
Gnomad MID
AF:
0.490
Gnomad NFE
AF:
0.504
Gnomad OTH
AF:
0.522
GnomAD4 exome
AF:
0.489
AC:
405255
AN:
829266
Hom.:
100772
Cov.:
11
AF XY:
0.482
AC XY:
210953
AN XY:
437846
show subpopulations
Gnomad4 AFR exome
AF:
0.671
Gnomad4 AMR exome
AF:
0.503
Gnomad4 ASJ exome
AF:
0.468
Gnomad4 EAS exome
AF:
0.376
Gnomad4 SAS exome
AF:
0.373
Gnomad4 FIN exome
AF:
0.490
Gnomad4 NFE exome
AF:
0.503
Gnomad4 OTH exome
AF:
0.500
GnomAD4 genome
AF:
0.539
AC:
81631
AN:
151420
Hom.:
22561
Cov.:
30
AF XY:
0.533
AC XY:
39399
AN XY:
73954
show subpopulations
Gnomad4 AFR
AF:
0.670
Gnomad4 AMR
AF:
0.507
Gnomad4 ASJ
AF:
0.473
Gnomad4 EAS
AF:
0.391
Gnomad4 SAS
AF:
0.355
Gnomad4 FIN
AF:
0.485
Gnomad4 NFE
AF:
0.504
Gnomad4 OTH
AF:
0.525
Alfa
AF:
0.523
Hom.:
4241
Bravo
AF:
0.551
Asia WGS
AF:
0.412
AC:
1433
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Benign:1
Benign, criteria provided, single submitterclinical testingUnidad de Genómica Garrahan, Hospital de Pediatría GarrahanJan 24, 2024This variant is classified as Benign based on local population frequency. This variant was detected in 44% of patients studied by a panel of primary immunodeficiencies. Number of patients: 42. Only high quality variants are reported. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
0.080
DANN
Benign
0.43

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs11556835; hg19: chr17-49231627; COSMIC: COSV50147123; COSMIC: COSV50147123; API